Plasma concentrations of YKL-40 in chemo-naive patients with metastatic colorectal cancer treated with FLOX with or without cetuximab: Results from the NORDIC VII study.
Line Schmidt Tarpgaard
No relevant relationships to disclose
Tormod Kyrre Guren
No relevant relationships to disclose
Bengt Glimelius
Research Funding - Lilly; Merck Serono
Per Pfeiffer
Consultant or Advisory Role - Merck Serono (U); Roche (U)
Research Funding - Merck Serono; Roche
Elin Kure
No relevant relationships to disclose
Mette K. N. Yilmaz
No relevant relationships to disclose
Halfdan Sorbye
Consultant or Advisory Role - Merck Serono (U); Novartis
Honoraria - Bayer Schering Pharma; Novartis; Roche
Research Funding - Merck Serono
Nina Keldsen
No relevant relationships to disclose
Eva Skovlund
No relevant relationships to disclose
Julia S. Johansen
No relevant relationships to disclose
Kjell Magne Tveit
Research Funding - Merck Serono; Sanofi